Abstract: A variety of medicinal compounds comprising Crocus sativus for the treatment of a plurality of medical ailments are described. A method of creating a Crocus sativus extract is also described. In addition, a variety of embodiments and methods of utilizing inhalation therapeutic delivery mechanisms including nebulizers and vaporizers for the vaporization of Crocus sativus comprising medicinal compounds and extracts are disclosed.
Abstract: Compositions comprising thermo-modified nutshells, for example hazelnut shells, are described herein. The compositions can also comprise one or more feed additives, pharmaceutically acceptable diluents and/or excipients. Also included are methods for producing the thermo-modified nutshell compositions, and methods for using the compositions to treat diarrhea and adsorb toxins as well as promote growth and improve the overall health in humans and other animals.
Abstract: It is an object of the present invention to provide a method for preparing a water extract of ashwagandha, which comprises increasing the amounts of withanone and withaferin A contained as active ingredients in the water extract of ashwagandha leaves. In addition, it is another object of the present invention to more economically and simply provide a pharmaceutical composition comprising ashwagandha leaves. The present invention relates to a method for preparing a water extract of ashwagandha leaves, which comprises extracting ashwagandha leaves with water in the presence of cyclodextrin, and a method for enhancing the anticancer activity of the water extract of ashwagandha leaves. The present invention also relates to a pharmaceutical composition for treating or preventing cancer, comprising the water extract of ashwagandha leaves. The present invention further relates to a pharmaceutical composition comprising dry powders of ashwagandha leaves and cyclodextrin.
Type:
Grant
Filed:
January 29, 2015
Date of Patent:
May 12, 2020
Assignees:
National Institute of Advanced Industrial Science and Technology, Kaul-Tech Co., Ltd.
Abstract: Compositions for reducing skin aging are disclosed herein. The compositions can be topically applied to a skin region to reduce or prevent skin wrinkles, fine lines, thinning skin, sagging skin, skin dryness, and skin itchiness.
Type:
Grant
Filed:
April 30, 2014
Date of Patent:
May 12, 2020
Assignee:
Kimberly-Clark Worldwide, Inc.
Inventors:
Scott W. Wenzel, David J. Tyrrell, Alencia Vanay Grice, Stephanie VandeVen Teat, Jeffery Richard Seidling
Abstract: Herbo-mineral formulation for prevention, treatment and management of Diabetes and method of preparing the same are disclosed herein. The disclosed herbo-mineral formulation includes herb and mineral elements which facilitate in treating Diabetes and Diabetes associated complications. Further the disclosed formulation has been observed to exhibit hypoglycemic, hypolipidemic, and pancreatic cell regenerative properties.
Abstract: A method/process is provided for extracting and processing sugarcane juice from sugarcane stalks to produce a shelf-stable natural juice product preserving policosanols naturally-occurring in raw sugarcane sticks. The method includes steps of: providing sugarcane stalks having a high sucrose level; extracting sugarcane juice from the sugarcane stalks using a roller mill apparatus; filtering the extracted sugarcane juice through a screen filter; stabilizing the pH of the juice in a non-acidic solution of calcium hydroxide to a pH level in the range of 7.4 to 7.6; flocculating the sugarcane juice with a mixture of water and at least one natural flocculate product; evaporating the sugarcane juice to form a sugarcane juice concentrate having a Brix in the range of 50° Bx to 60° Bx; and extracting the sugarcane juice concentrate from the evaporator, while maintaining a maximum sugarcane juice temperature never exceeding 70° C. throughout the process.
Abstract: A method for producing a cellulose composite containing cellulose and a polysaccharide, wherein a median size of colloidal cellulose composites contained in the cellulose composite as measured by a dynamic light scattering method is 0.85 ?m or more, the method including treating a mixture containing cellulose, a polysaccharide and an aqueous medium together in a wet process, wherein a solid content is controlled to be 35 mass % or more, and temperature is set at 80° C. or less.
Abstract: An object of the present invention is to provide an agent for sedating the response of skin to external stimulation. The aforementioned object was achieved by finding a component that promotes CD39 gene expression in Langerhans cells. More specifically, the present invention is based on the finding that the combination of carboxymethyl-beta glucan or a salt thereof polyoxyethylene (POE)/polyoxypropylene (POP) random copolymer dimethyl ether and rosewater promotes CD39 gene expression.
Type:
Grant
Filed:
March 12, 2014
Date of Patent:
April 14, 2020
Assignee:
Shiseido Company, Ltd.
Inventors:
Junichi Hosoi, Kaori Inoue, Shoko Yamada, Minako Sato
Abstract: The present invention relates to a new composition for use in the treatment of cough comprising, as sole active principles, Plantago lanceolata extract, honey, cane sugar, Thymus sp. extract and optionally Sambucus nigra juice.
Abstract: Herbo-mineral formulation for prevention, treatment and management of Diabetes and method of preparing the same are disclosed herein. The disclosed herbo-mineral formulation includes herb and mineral elements which facilitate in treating Diabetes and Diabetes associated complications. Further the disclosed formulation has been observed to exhibit hypoglycemic, hypolipidemic, and pancreatic cell regenerative properties.
Abstract: Compositions for reducing skin aging are disclosed herein. The compositions can be topically applied to a skin region to reduce or prevent skin wrinkles, fine lines, thinning skin, sagging skin, skin dryness, and skin itchiness.
Type:
Grant
Filed:
April 30, 2014
Date of Patent:
February 4, 2020
Assignee:
Kimberly-Clark Worldwide, Inc.
Inventors:
Scott W. Wenzel, David J. Tyrrell, Alencia Vanay Grice, Stephanie VandeVen Teat, Jeffery Richard Seidling
Abstract: The present invention relates to a maple syrup product having a low water content. The maple syrup product retains the physical and palatable properties of untreated maple syrup while having a prolonged shelf-life. It can be advantageously used to sweeten beverages (such as hot beverages) and in the manufacture of pharmaceutical compositions (such as throat lozenges) and/or confectionery.
Abstract: The present invention relates to processes for producing treated olive mill process water (OMPW). In some exemplary embodiments, the treated OMPW is used in the preparation/production of body care products.
Type:
Grant
Filed:
July 20, 2015
Date of Patent:
January 14, 2020
Assignees:
The United States of America, as represented by The Secretary of Agriculture, McEvoy of Marin, LLC
Inventors:
Rebecca R Milczarek, Jeffrey A Creque, John Bailey, Ellen Roggemann
Abstract: A method for processing sugarcane juice from raw sugarcane stalks to produce various forms of a natural sugarcane juice product preserves policosanols naturally occurring in the raw sugarcane stalks, resulting in policosanol-rich natural sugarcane juice-based products such as a drinking beverage, a concentrated sweetening agent, and a nutraceutical product. The method may include steps of providing sugarcane stalks having high policosanol concentrations; extracting sugarcane juice from the sugarcane stalks via a series of roller mills; filtering the extracted sugarcane juice; stabilizing the pH of the juice in a non-acidic solution of calcium hydroxide; flocculating the sugarcane juice to remove undesirable impurities; optionally, evaporating the sugarcane juice to form a policosanol-rich sugarcane juice concentrate and extracting the sugarcane juice concentrate from the evaporator.
Abstract: The invention of the present Application provides a standardized method to obtain an extract and the extract from leaves of Swinglea glutinosa , wherein the method yields an amount of extract that is about 60% the weight of the Swinglea glutinosaleaves.
Type:
Grant
Filed:
February 29, 2016
Date of Patent:
November 12, 2019
Assignee:
GOWAN CROP PROTECTION LIMITED
Inventors:
Jaime Toro Restrepo, Sandra Patricia Zapata Rojas, James Alberto Jiménez Martinez
Abstract: The present invention relates to a method for maintaining normoglycemia in a mammal in need thereof, preferably a critically ill patient suffering from acute stress, and to a method for preventing or limiting renal ischemia-reperfusion (I/R) in a mammal, preferably in a critically ill patient suffering from acute stress.
Abstract: The present disclosure relates to a method of increasing fertility of a male subject, wherein the male subject suffers from reduced fertility resulting from a medication, wherein the medication inhibits sperm cell production by inhibiting spermatogenesis in a testis of the male subject, and wherein the method comprises administering to the male subject an effective amount of an extract of Costus speciosus in combination with the medication to prevent, and/or reduce the inhibition of sperm cell production by the medication to increase the fertility of the male subject.
Type:
Grant
Filed:
November 8, 2016
Date of Patent:
August 20, 2019
Assignee:
King Abdulaziz University
Inventors:
Dalia Mostafa Mohammed Domiaty, Sherifa Shaker Hamed Hassaballa
Abstract: Disclosed herein is a refined product obtained from a rice hull, which consists essentially of a type II arabinogalactan having a number average molecular weight in the range of 56 to 103 kDa. Also disclosed are a process for producing the refined product and use of the refined product for enhancing the biological activity of innate immune cells, as well as for treating allergy and cancer.
Abstract: The present invention relates to a composition for promoting osteoblast or cartilage cell differentiation. More particularly, the present invention relates to a composition, which includes stauntonia hexaphylla leaf extract that may be safely used without toxicity and side effects by using a natural ingredient, for promoting bone (tissue) formation to be used for suppressing and treating bone and cartilage tissue damage. A pharmaceutical composition including the stauntonia hexaphylla leaf extract according to the present invention as an active ingredient may be used as a medicine for periodontitis or osteoporosis to treat or prevent periodontitis or osteoporosis.
Inventors:
Chul Yung Choi, Sang O Pan, Hee Jin Seol, Gyu Ok Lee, Wook Jin Jang, Hee Sook Kim, Jae Yong Kim, HuWon Kang, Dong Wook Lee, Sun Oh Kim, Jae Gap Kim, JoonYung Park